Survey of anaerobic susceptibility patterns: A French multicentre study

International Journal of Antimicrobial Agents

Volumn 10, Issue 3, 1998, Pages 229-236

  Mory, F ^a   Lozniewski, A ^a   Bland, S ^b   Sedallian, A ^b   Grollier, G ^c   Girard Pipau, F ^d   Paris, M F ^e   Dubreuil, L ^e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Centre Hospitalier de la Region d'Annecy   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e UNIV LILLE   (France)

Author keywords

Anaerobes; Antibiotic patterns; Resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN; TIMENTIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEROIDES FRAGILIS; CLOSTRIDIUM; CONTROLLED STUDY; DILUTION; FRANCE; FUSOBACTERIUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PEPTOSTREPTOCOCCUS; PREVOTELLA; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BACTEROIDACEAE; DRUG RESISTANCE, MICROBIAL; FRANCE; GRAM-POSITIVE COCCI; GRAM-POSITIVE RODS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0032142840     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00041-7     Document Type: Article

References (21)

1. Dubreuil L, Derriennic M, Sedallian A et al. Evaluation in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodical surveys. Infection. 17:1989;197-200.
2. Dubreuil L, Breuil J, Dublanchet A et al. Survey of the susceptibility patterns of Bacteroides fragilis group strains in france from 1977 to 1979. Eur J Clin Microbiol Infect Dis. 11:1992;1094-1099.
3. Dublanchet A, Caillon J, Edmond J.P et al. Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J. Clin Microbiol. 5:1986;346-347.
4. Haggoud A, Reysset G, Sebald M. Cloning of a Bacteroides fragilis chromosomal determinant coding for 5-nitroimidazole resistance. FEMS Microbiol Lett. 95:1992;1-6.
5. Appelbaum PC, Spangler SK, Pankuch G, et al. Properties of a β-lactamase from a strain of Clostridium clostridioforme. Program Abstr. 32th Intersci. Conf Antimicrob Agents Chemother Abstr 1273, 1992.
6. Appelbaum PC, Spangler SK, Jacobs MR. ß-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. Centers. Antimicrob Agents Chemother. 34:1990;1546-1550.
7. Cuchural GJ, Michael JR, Malamy M et al. β-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother. 30:1986;645-648.
8. Heldberg M, Edlund C, Lindqvist L et al. Purification and characterisation of an imipenem hydrolysing metallo-β-lactamase from Bacteroides fragilis. J Antimicrob Chemother. 29:1992;105-113.
9. Brazier JS, Citron DM, Goldstein EJC A selective medium for Fusobacterium spp. J. Appl Bacteriol. 71:1991;343-346.
10. National Committee for Clinical Laboratory Standards. Methods for antimicrobial testing of anaerobic bacteria-second edition; Approved standard, NCCLS publication M11-A3. National Committee for Clinical Laboratory Standards, Villanova Pa. 1993.
11. National Committee for Clinical Laboratory Standards. Reference dilution procedure for antimicrobial testing of anaerobic bacteria. Approved standard, NCCLS publication M-11T. National Committee for Clinical Laboratory Standards, Villanova Pa. 1979.
12. Ericsson HM, Sherris JC. Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathol Microbiol Scand. 27:1971.
13. Wilkins TD, Chalgren S. Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother. 10:1976;926-928.
14. Acar J, Carret G, Cavallo JD et al. Communiqué de l'antibiogramme de la Société Française de microbiologie. Valeurs critiques pour l'antibiogramme. Path Biol. 45:1997;1-20.
15. Wexler HM. Susceptibility testing of anaerobes bacteria:myth, magic, or method? Clin Microbiol Rew. 4:1991;470-484.
16. Grollier G, Mory F, Quentin C et al. Survey of anaerobic susceptibility patterns: A French multicentric study. Path Biol. 42:1994;498-504.
17. Bland S, Sedallian A, Grollier G et al. In vitro activity of three carbapenems biapenem, imipenem and meropenem and some other antibiotics against anaerobic bacteria. Path Biol. 43:1995;289-293.
18. Patey O, Varon E, Podglajen I et al. Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the Bacteroides fragilis group. J Antimicrob Chemother. 33:1994;1029-1034.
19. Dubreuil L, Houcke I, Mouton Y et al. In vitro activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrob Agents Chemother. 40:1996;2266-2270.
20. Dubreuil L, Houcke I, Singer E et al. Comparative activity of Faropenem and other antimicrobial agents against 462 clinical anaerobes (abstract). International Congress of Antimicrobial Agents and Chemotherapy (ICAAC) Toronto, Ontario, Canada. 222:1996.
21. Eley A, Harmas AE, Bennett KW. In vitro activity of twelve antibiotics against clinical isolates of Bilophila wadsworthia. J Antimicrob Chemother. 29:1992;468-470.